C
Cadrenal Therapeutics D
D
CVKD
13.470
USD
0.24
(1.81%)
مغلق
حجم التداول
8
الربح لكل سهم
-7
العائد الربحي
-
P/E
-1
حجم السوق
26,491,112
العنوان: Cadrenal Therapeutics Inc
القطاع: Healthcare
الصناعة: Biotechnology
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.